+Compare
INSP
Stock ticker: NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
4.26B

INSP Inspire Medical Systems Forecast, Technical & Fundamental Analysis

a developer of implantable neurostimulation systems to treat obstructive sleep apnea

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for INSP with price predictions
07:00 PM EST Nov 26, 2023

INSP's RSI Oscillator ascends from oversold territory

The RSI Indicator for INSP moved out of oversold territory on November 14, 2023. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In of the 24 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 22, 2023. You may want to consider a long position or call options on INSP as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for INSP just turned positive on November 15, 2023. Looking at past instances where INSP's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INSP advanced for three days, in of 327 cases, the price rose further within the following month. The odds of a continued upward trend are .

INSP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INSP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for INSP entered a downward trend on November 15, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.819) is normal, around the industry mean (25.079). P/E Ratio (0.000) is within average values for comparable stocks, (79.545). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.242). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (7.369) is also within normal values, averaging (45.510).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. INSP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.4B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 2%. For the same Industry, the average monthly price growth was 11%, and the average quarterly price growth was 702%. BOEUF experienced the highest price growth at 168%, while LNDZF experienced the biggest fall at -74%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -29%. For the same stocks of the Industry, the average monthly volume growth was -13% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 55
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

INSP is expected to report earnings to fall 35.07% to -18 cents per share on February 06

Inspire Medical Systems INSP Stock Earnings Reports
Q4'23
Est.
$-0.19
Q3'23
Beat
by $0.29
Q2'23
Beat
by $0.16
Q1'23
Beat
by $0.13
Q4'22
Beat
by $0.72
The last earnings report on November 07 showed earnings per share of -28 cents, beating the estimate of -57 cents. With 415.12K shares outstanding, the current market capitalization sits at 4.26B.
A.I. Advisor
published General Information

General Information

a developer of implantable neurostimulation systems to treat obstructive sleep apnea

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
5500 Wayzata Boulevard
Phone
+1 844 672-4357
Employees
755
Web
https://www.inspiresleep.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HPS12.920.04
+0.31%
John Hancock Preferred Income Fund III
DEUS44.83-0.05
-0.11%
Xtrackers Russell US Multifactor ETF
BBUS82.00-0.12
-0.15%
JPMorgan BetaBuilders US Equity ETF
COPJ17.05-0.17
-1.01%
Sprott Junior Copper Miners ETF
PLTM8.95-0.10
-1.10%
GraniteShares Platinum Trust

INSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSP has been loosely correlated with RVTY. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if INSP jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSP
1D Price
Change %
INSP100%
+0.06%
RVTY - INSP
52%
Loosely correlated
-2.04%
PODD - INSP
49%
Loosely correlated
-0.11%
ISRG - INSP
48%
Loosely correlated
-0.95%
PEN - INSP
48%
Loosely correlated
-0.81%
ESTA - INSP
46%
Loosely correlated
-6.28%
More

Groups containing INSP

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSP
1D Price
Change %
INSP100%
+0.06%
challenging disorders
(undefined stocks)
77%
Closely correlated
-0.35%
medical research
(undefined stocks)
56%
Loosely correlated
+0.10%
medical service
(undefined stocks)
54%
Loosely correlated
+0.07%
Medical Specialties
(undefined stocks)
52%
Loosely correlated
-0.03%
Medical Specialties
(undefined stocks)
52%
Loosely correlated
-0.03%
More